VKaramyan TTUHSC 3.jpeg (IMAGE) Texas Tech University Health Sciences Center Caption In his most recent study, TTUHSC’s Vardan Karamyan, Ph.D., led a collaborative investigation to evaluate the potential of neurolysin as a therapeutic target for stroke. Credit TTUHSC Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.